Diagnosis of HER-2 positive breast cancer

摘要

A diagnostic technology for breast cancer, in particular, caused by Her-2 copy number variation is provided. Said diagnostic technology identifies the amplification attributable to Her-2 copy number variations and thus allows correct, convenient and rapid diagnosis of breast cancer caused by the amplification attributable to Her-2 copy number variations. As such, said diagnostic technology is highly beneficial for customized treatments of breast cancer such as the therapy using Her-2 antibody (e.g. Herceptin).